FIRST OMNIBUS AMENDMENT TO THE SECURITIES PURCHASE AGREEMENT AND SENIOR SECURED CONVERTIBLE NOTESSecurities Purchase Agreement and Senior Secured Convertible Notes • January 29th, 2020 • Mri Interventions, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledJanuary 29th, 2020 Company IndustryThis FIRST OMNIBUS AMENDMENT TO THE SECURITIES PURCHASE AGREEMENT AND SENIOR SECURED CONVERTIBLE NOTES (this “First Amendment”) is dated as of January 29, 2020 and is made in reference to that (i) certain Securities Purchase Agreement, dated as of January 11, 2020 (the “Purchase Agreement”), by and among MRI Interventions, Inc., a Delaware corporation (the “Company”), the investors identified on the signature pages thereto (the “Investors”), and Petrichor Opportunities Fund I LP, as collateral agent (collectively, the “Parties”), and (ii) those certain Notes (as defined below).
AMENDMENT TO SECURITIES PURCHASE AGREEMENT AND SENIOR SECURED CONVERTIBLE NOTESSecurities Purchase Agreement and Senior Secured Convertible Notes • January 24th, 2014 • Resonant Inc
Contract Type FiledJanuary 24th, 2014 CompanyThis Amendment to Securities Purchase Agreement and Senior Secured Convertible Notes (this “Amendment”) is made and entered into as of January 17, 2014, by and among Resonant Inc., a Delaware corporation (the “Company”), and the Required Holders. Except where otherwise defined herein, the capitalized terms used in this Amendment shall have the respective meanings assigned to such terms in the Agreement (as such term is defined in Recital A below) or the Notes (as such term is defined in Recital B below)), as applicable. This Amendment is made with reference to the following Recitals:
FIRST ADDENDUM TO THE SECURITIES PURCHASE AGREEMENT AND SENIOR SECURED CONVERTIBLE NOTES Between PSYENCE BIOMEDICAL LTD., a corporation existing under the laws of Ontario, Canada (the "Company") PSYENCE BIOMED II CORP., a corporation existing under...Securities Purchase Agreement and Senior Secured Convertible Notes • August 19th, 2024 • Psyence Biomedical Ltd. • Pharmaceutical preparations
Contract Type FiledAugust 19th, 2024 Company IndustryHARRADEN CIRCLE INVESTORS, LP, a fund, account, and/other investment vehicle managed by Harraden Circle Investments, LLC ("HCI")
THIRD OMNIBUS AMENDMENT TO THE SECURITIES PURCHASE AGREEMENT AND SENIOR SECURED CONVERTIBLE NOTESSecurities Purchase Agreement and Senior Secured Convertible Notes • August 1st, 2023 • ClearPoint Neuro, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledAugust 1st, 2023 Company IndustryThis THIRD OMNIBUS AMENDMENT TO THE SECURITIES PURCHASE AGREEMENT AND SENIOR SECURED CONVERTIBLE NOTES (this “Third Amendment”) is dated as of July 31, 2023 and is made in reference to that certain Securities Purchase Agreement, dated as of January 11, 2020 (as heretofore has been, and as hereafter may be, amended, restated or otherwise modified, the “Purchase Agreement”), by and among ClearPoint Neuro, Inc. (previously named MRI Interventions, Inc.), a Delaware corporation (the “Company”), the investors identified on the signature pages thereto (the “Investors”), Petrichor Opportunities Fund I LP, as resigning collateral agent (the “Resigning Agent”) and PTC Therapeutics, Inc. (“PTC”), as successor agent as set forth below (collectively, the “Parties”) and the Notes (as hereinafter defined) issued thereunder.
SECOND OMNIBUS AMENDMENT TO THE SECURITIES PURCHASE AGREEMENT AND SENIOR SECURED CONVERTIBLE NOTESSecurities Purchase Agreement and Senior Secured Convertible Notes • December 29th, 2020 • ClearPoint Neuro, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledDecember 29th, 2020 Company IndustryThis SECOND OMNIBUS AMENDMENT TO THE SECURITIES PURCHASE AGREEMENT AND SENIOR SECURED CONVERTIBLE NOTES (this “Second Amendment”) is dated as of December 29, 2020 and is made in reference to that (i) certain Securities Purchase Agreement, dated as of January 11, 2020 (as heretofore has been, and as hereafter may be, amended, restated or otherwise modified, the “Purchase Agreement”), by and among ClearPoint Neuro, Inc. (previously named MRI Interventions, Inc.), a Delaware corporation (the “Company”), the investors identified on the signature pages thereto (the “Investors”), and Petrichor Opportunities Fund I LP, as collateral agent (collectively, the “Parties”), and (ii) those certain Second Closing Notes (as defined below).
THIRD AMENDMENT TO SECURITIES PURCHASE AGREEMENT AND THIRD AMENDMENT TO SENIOR SECURED CONVERTIBLE NOTESSecurities Purchase Agreement and Senior Secured Convertible Notes • April 15th, 2024 • Astra Space, Inc. • Transportation services
Contract Type FiledApril 15th, 2024 Company IndustryThis THIRD AMENDMENT TO SECURITIES PURCHASE AGREEMENT AND THIRD AMENDMENT TO SENIOR SECURED CONVERTIBLE NOTES (this “Amendment”), dated as of April 10, 2024 (the “Effective Date”), is entered into by and among ASTRA SPACE, INC., a Delaware limited liability company (“Astra”), each of the Subsidiaries of Astra (together with Astra, collectively, the “Note Parties”), and each of the investors listed on the Schedule of Buyers attached hereto (together with their successors and assigns, individually, a “Buyer” and collectively, the “Buyers”).